Moreover, 5-Fluorouracil (5-FU)-based clinical chemotherapy increased the expression and activation of NLRP3 inflammasome in oral squamous cell carcinoma (OSCC) tissues, which then mediated the chemoresistance [40]. Here, NLRP3 is linked to oral cavity squamous cell carcinoma.